New approach to cancer research aims to accelerate studies and reduce cost

New approach to cancer research aims to accelerate studies and reduce cost

Hagop Kantarjian, M.D.

HOUSTON ― A new model for improving how clinical trials are developed and conducted by bringing together academic cancer experts and pharmaceutical companies is being tested by research experts at The University of Texas MD Anderson Cancer Center. An assessment of the alternative research model was published in the May 14 online issue of Cancer. The model was piloted in a multi-study leukemia research program established between MD Anderson and Bristol-Myers Squibb (BMS) and revamped how studies were […]